Filing Details
- Accession Number:
- 0001209191-11-035437
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-06-17 20:50:34
- Reporting Period:
- 2011-06-15
- Filing Date:
- 2011-06-17
- Accepted Time:
- 2011-06-17 19:50:34
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1316175 | Anthera Pharmaceuticals Inc | ANTH | Pharmaceutical Preparations (2834) | 201852016 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1120362 | F Paul Truex | C/O Anthera Pharmaceuticals, Inc. 25801 Industrial Boulevard, Suite B Hayward CA 94545 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2011-05-31 | 5,122 | $0.00 | 86,000 | No | 5 | G | Direct | |
| Common Stock | Acquisiton | 2011-05-31 | 5,122 | $0.00 | 697,125 | No | 5 | G | Indirect | By trust |
| Common Stock | Disposition | 2011-06-15 | 15,000 | $8.30 | 682,125 | No | 4 | S | Indirect | By trust |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 5 | G | Direct | |
| No | 5 | G | Indirect | By trust |
| No | 4 | S | Indirect | By trust |
Footnotes
- On May 31, 2011, the Reporting Person transferred 5,122 shares to The 2005 Truex Family Trust u/d/t April 20, 2005.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 1, 2011.
- The price reported in Column 4 is a weighted average price. These Shares were sold in multiple transactions at prices ranging from $8.15 to $8.43, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of Shares sold at each separate price within the range set forth in this footnote.
Billionaire Hedge Funds
